Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03143920 · ClinicalTrials.gov registry record · Early Phase 1
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
A Early Phase 1 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT03143920: Clinical Trial Early Phase 1 study, sponsored by University of California, San Diego.
NCT03143920 is a Early Phase 1 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 11 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03143920, a Early Phase 1 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Pilot study to determine feasibility for treating patients with two chronic inflammatory conditions of the urinary bladder: chronic interstitial cystitis and recurrent urinary tract infections using a standardized hyperbaric oxygen treatment plan. Presently there are no good treatments for these conditions and hyperbaric oxygen may be a safe and readily accessible therapy as it has proven successful an another type of chronic inflammatory condition of the urinary bladder known as "radiation cystitis". The study will determine if patients will consider this an acceptable treatment for their conditions and that it is well tolerated.
Primary Outcome
The primary outcome will be the number of patients that enroll in the study relative to the number offered enrollment and reported as a percentage of total patients offered enrollment.
Interventions
- COMBINATION_PRODUCT Hyperbaric Oxygen Therapy-
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2022-07-07 |
| Phase | Early Phase 1 |
Why NCT03143920 stopped before completion
NCT03143920 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Therapy- is the first listed.
NCT03143920 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03143920 about?
NCT03143920 is a clinical study titled "Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder". Pilot study to determine feasibility for treating patients with two chronic inflammatory conditions of the urinary bladder: chronic interstitial cystitis and recurrent urinary tract infections using a standardized hyperbaric oxygen treatment plan. Presently there are no good treatments for these con...
What is the current status of trial NCT03143920?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2017-11-01. Estimated completion is 2022-07-07.
What interventions are being tested in trial NCT03143920?
The interventions under investigation include: Hyperbaric Oxygen Therapy- (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03143920?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03143920's enrollment target sits among peer trials
11 1600th of 2000 higher than 373 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI